LLY

1,047.45

-0.3%↓

JNJ

203.22

+0.34%↑

ABBV

229.4

-1.63%↓

UNH

313.56

+2.24%↑

AZN

88.84

-0.21%↓

LLY

1,047.45

-0.3%↓

JNJ

203.22

+0.34%↑

ABBV

229.4

-1.63%↓

UNH

313.56

+2.24%↑

AZN

88.84

-0.21%↓

LLY

1,047.45

-0.3%↓

JNJ

203.22

+0.34%↑

ABBV

229.4

-1.63%↓

UNH

313.56

+2.24%↑

AZN

88.84

-0.21%↓

LLY

1,047.45

-0.3%↓

JNJ

203.22

+0.34%↑

ABBV

229.4

-1.63%↓

UNH

313.56

+2.24%↑

AZN

88.84

-0.21%↓

LLY

1,047.45

-0.3%↓

JNJ

203.22

+0.34%↑

ABBV

229.4

-1.63%↓

UNH

313.56

+2.24%↑

AZN

88.84

-0.21%↓

Inicio・Lista de Acciones・Lisata Therapeutics

L
Lisata Therapeutics

Abierto

1.95 -4.41

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.88

Máximo

2.02

Métricas clave
By Trading Economics
Empleados	26

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+638.92% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-4.5M 16M
Apertura anterior	6.36
Cierre anterior	1.95

Lisata Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

19 nov 2025, 23:36 UTC

Acciones populares

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 nov 2025, 22:13 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 nov 2025, 21:55 UTC

Principales Movimientos del Mercado

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 nov 2025, 21:43 UTC

Adquisiciones, fusiones, absorciones

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 nov 2025, 23:55 UTC

Charlas de Mercado

Gold Rises on Possible Investment Demand -- Market Talk

19 nov 2025, 23:54 UTC

Charlas de Mercado

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 nov 2025, 23:47 UTC

Ganancias

Lenovo Group 2Q EPS $2.52 >0992.HK

19 nov 2025, 23:46 UTC

Ganancias

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 nov 2025, 23:45 UTC

Ganancias

Lenovo Group 2Q Rev $20.5B >0992.HK

19 nov 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 nov 2025, 23:42 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

19 nov 2025, 23:41 UTC

Ganancias

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 nov 2025, 23:41 UTC

Ganancias

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 nov 2025, 23:40 UTC

Ganancias

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 nov 2025, 22:55 UTC

Ganancias

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 nov 2025, 22:41 UTC

Ganancias

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 nov 2025, 22:30 UTC

Adquisiciones, fusiones, absorciones

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 nov 2025, 22:30 UTC

Ganancias

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 nov 2025, 22:30 UTC

Adquisiciones, fusiones, absorciones

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 nov 2025, 22:27 UTC

Adquisiciones, fusiones, absorciones

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 nov 2025, 22:08 UTC

Ganancias

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 nov 2025, 22:00 UTC

Ganancias

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 nov 2025, 21:58 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 nov 2025, 21:52 UTC

Ganancias

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 nov 2025, 21:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

19 nov 2025, 21:49 UTC

Charlas de Mercado

Ganancias

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 nov 2025, 21:38 UTC

Ganancias

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 nov 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Palo Alto Networks to Buy Chronosphere for $3.35B

19 nov 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 nov 2025, 21:24 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Comparación entre iguales

Cambio de precio

Lisata Therapeutics Esperado

Precio Objetivo

By TipRanks

638.92% repunte

Estimación a 12 meses

Media 15 USD 638.92%

Máximo 15 USD

Mínimo 15 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Lisata Therapeutics Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Lisata Therapeutics Dist en los últimos 3 meses.

Finanzas

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.